YSM News and Recognition
Evaluating different generations of diabetes meds head-to-head for their relative cardiovascular benefits; looking at the apparent relationship between PTSD and immune activation; and internal tremors join the expanding list of Long COVID symptoms.
News
- August 26, 2024
In the first head-to-head comparison of second-line diabetes medications, researchers have identified which drugs are most effective at lowering cardiovascular disease risk.
- August 23, 2024
A new study utilized positron emission tomography imaging with the radiotracer [11C]PBR28, to measure 18-kDa translocator protein to better understand microglia, the resident immune cells in the brains of individuals with PTSD.
- August 26, 2024
An ongoing study by Yale scientists has uncovered another nagging symptom of Long COVID: internal tremors that patients feel but are hard for health providers to detect.
- August 21, 2024
Fibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers have used single-cell sequencing technology to provide the first high-resolution atlas of this disease, revealing a previously unrecognized immune signature.
- August 19, 2024Source: Yale News
Those with more severe Long COVID are more likely to miss more workdays or not return to work at all, a new study finds.
- August 15, 2024Source: Yale News
In a Q&A, Michael C. Crair, PhD, Yale’s vice provost for research, discusses Yale's ongoing research enterprise and the role of federal funding for basic research.
- August 26, 2024
The 40 new Physician Associate (PA) Program students in Yale School of Medicine’s PA Class of 2026 were welcomed to the profession on August 23, receiving white coats and stethoscopes before a crowd of family, friends, and YSM community members in Mary S. Harkness Hall.
Recognition
Wang Gets Funding to Study Poor Heart Health Related to Incarceration
Emily Wang, MD, MAS, professor of medicine and of public health, and director of the SEICHE Center for Health and Justice, is co-leader of a five-year research project funded by the American Heart Association and the Robert Wood Johnson Foundation. With DeAnna Hoskins, MA, president and CEO of JustLeadershipUSA, a national organization based in New York, Wang and colleagues will explore why people who are in prison, along with their family members, are likely to have an increased risk of poor health, especially poor heart health. They will collect data to determine what health risk factors may be most prevalent among people in prison and their family members and what types of interventions might be most successful in improving their health.
Bassily-Marcus Will Be YNHHS Chief of Surgical Intensive Care
Adel M. Bassily-Marcus, MD, has been named chief of surgical intensive care for Yale New Haven Health System, effective September 1. Bassily-Marcus, a professor at Icahn School of Medicine at Mount Sinai, brings more than 30 years of experience to Yale. His research on critical care management and procedures has led to the development of national and international guidelines on managing critically ill patients. He has also established innovative programs that include critical care simulation training, which is part of the core curriculum for all medical students at Mount Sinai.
Sharifi Will Be General Pediatrics Section Chief for YSM and Yale New Haven Children's Hospital
Mona Sharifi, MD, MPH, associate professor of pediatrics (general pediatrics) and of biomedical informatics & data science at YSM, and associate professor of biostatistics (health informatics) at the Yale School of Public Health, has been named section chief of general pediatrics at YSM and at Yale New Haven Children’s Hospital, effective September 1.
Shin Earns Funding for Immunodeficiency Research
Junghee Jenny Shin, MD, PhD, assistant professor of medicine (rheumatology, allergy & immunology), has received a research grant from the Immune Deficiency Foundation. The goal of Shin’s research is to predict the severity of clinical symptoms for individuals with CD40LD, or X-linked hyper IgM syndrome, a rare inborn error of immunity that occurs in one out of every 1 million live births.